Acute rhabdomyolysis associated with troglitazone.
Yokoyama
M
M
Izumiya
Y
Y
Yoshizawa
M
M
Usuda
R
R
D002839:Chromans / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007527:Isoenzymes; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D007527:Isoenzymes; D013844:Thiazoles; D045162:Thiazolidinediones; D003402:Creatine Kinase; D000077288:Troglitazone; D005905:Glyburide